title: [Imiquimod in the treatment of lentigo maligna].
authors.affiliation: Servicio de Dermatología, Instituto Valenciano de Oncología, Valencia, España. eduyame@meditex.es
authors.forename: E
authors.initials: E
authors.lastname: Nagore
authors.forename: R
authors.initials: R
authors.lastname: Botella-Estrada
mesh_terms: D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D000634:Aminoquinolines / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001706:Biopsy; D000075202:Contraindications; D017679:Cryotherapy; D018450:Disease Progression; D017277:Drug Approval; D005260:Female; D006801:Humans; D018327:Hutchinson's Melanotic Freckle / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D000077271:Imiquimod; D008297:Male; D008545:Melanoma / Q000175:diagnosis / Q000473:pathology / Q000517:prevention & control; D018613:Microscopy, Confocal; D015580:Mohs Surgery; D009361:Neoplasm Invasiveness; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod